We’re pleased to present an on-demand option for the 2024 Onco-Nephrology Symposium, originally held live on September 13-14, 2024. This program is designed for the entire healthcare team managing patients with both cancer and kidney disease, offering a comprehensive look at the multidisciplinary nature of onco-nephrology.
Leading experts in plasma cell disorders—including multiple myeloma, amyloidosis, and monoclonal gammopathies—along with distinguished speakers on CAR T cell and other biologic therapies, thrombotic microangiopathy, and cardio-renal syndromes, present a comprehensive array of topics at the intersection of cancer and kidney disease. For further information about this program and session topics, view the brochure from the live course.
- Outline a comprehensive assessment and treatment of thrombotic microangiopathy
- Strategize a treatment plan for the patient with MGRS as part of a multidisciplinary team
- Effectively utilize novel diagnostic techniques to diagnose monoclonal disorders
- Recognize renal and non-renal toxicities of modern cancer therapy
- Formulate an treatment plan for kidney transplant patients who receive CAR T cell therapy
- Assimilate genetic testing data in the evaluation of thrombotic microangiopathy
- Review assessment and management of glomerular disorders in cancer patients
- Apprehend modern therapeutic approaches to small renal masses and cancers of the kidney
Reviews
There are no reviews yet.